| Amanda Kull, MD | |
|
1648 Ellis St Ste 301, Bozeman, MT 59715-8811 | |
| (406) 556-9798 | |
| (406) 556-9795 |
| Full Name | Amanda Kull |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology |
| Experience | 7 Years |
| Location | 1648 Ellis St Ste 301, Bozeman, Montana |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497287775 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 104963 (Montana) | Primary |
| 207Y00000X | Otolaryngology | 10957163-1205 (Utah) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bozeman Health Deaconess Hospital | Bozeman, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bridger Ear, Nose And Throat Pllc | 7315950037 | 3 |
News Archive
For those who are diagnosed and have begun treatment for HIV, it is standard practice to regularly monitor viral load in the blood to assess response to treatment.
Novavax, Inc. announced today that it has successfully completed a pre-clinical safety and efficacy study of its RSV vaccine candidate in cotton rats. Results from this study are needed to support an Investigational New Drug (IND) application to advance this novel recombinant F protein particle based RSV (RSV-F) vaccine candidate into clinical development. This vaccine candidate is composed of recombinant 'F' or 'fusion' protein of RSV which is used by the virus to infect and fuse with cells in the respiratory tract and cause disease.
eCareSoft's eCS has received Complete Inpatient EHR Certification deeming the electronic health record (EHR) software capable of enabling hospitals and their affiliates to meet the Stage 1 meaningful use measures required to qualify for funding under the American Recovery and Reinvestment Act (ARRA).
CardioCell LLC announces two new clinical trials using its allogeneic stem-cell therapy to treat subjects with acute myocardial infarction (AMI), a problem facing more than 1.26 million Americans annually.
The Chemistry, Food & Drugs Division of the Trinidad & Tobago Ministry of Health approved the introduction of Telaprevir to the market, an innovative therapy that significantly increases the cure rate from Hepatitis C, and it is indicated for patients infected with the genotype 1 virus. Telaprevir is available in Trinidad under the trade brand INCIVO®.
› Verified 2 days ago
| Entity Name | Bridger Ear, Nose And Throat Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407878549 PECOS PAC ID: 7315950037 Enrollment ID: O20060725000431 |
News Archive
For those who are diagnosed and have begun treatment for HIV, it is standard practice to regularly monitor viral load in the blood to assess response to treatment.
Novavax, Inc. announced today that it has successfully completed a pre-clinical safety and efficacy study of its RSV vaccine candidate in cotton rats. Results from this study are needed to support an Investigational New Drug (IND) application to advance this novel recombinant F protein particle based RSV (RSV-F) vaccine candidate into clinical development. This vaccine candidate is composed of recombinant 'F' or 'fusion' protein of RSV which is used by the virus to infect and fuse with cells in the respiratory tract and cause disease.
eCareSoft's eCS has received Complete Inpatient EHR Certification deeming the electronic health record (EHR) software capable of enabling hospitals and their affiliates to meet the Stage 1 meaningful use measures required to qualify for funding under the American Recovery and Reinvestment Act (ARRA).
CardioCell LLC announces two new clinical trials using its allogeneic stem-cell therapy to treat subjects with acute myocardial infarction (AMI), a problem facing more than 1.26 million Americans annually.
The Chemistry, Food & Drugs Division of the Trinidad & Tobago Ministry of Health approved the introduction of Telaprevir to the market, an innovative therapy that significantly increases the cure rate from Hepatitis C, and it is indicated for patients infected with the genotype 1 virus. Telaprevir is available in Trinidad under the trade brand INCIVO®.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amanda Kull, MD 1648 Ellis St Ste 301, Bozeman, MT 59715-8811 Ph: (406) 556-9798 | Amanda Kull, MD 1648 Ellis St Ste 301, Bozeman, MT 59715-8811 Ph: (406) 556-9798 |
News Archive
For those who are diagnosed and have begun treatment for HIV, it is standard practice to regularly monitor viral load in the blood to assess response to treatment.
Novavax, Inc. announced today that it has successfully completed a pre-clinical safety and efficacy study of its RSV vaccine candidate in cotton rats. Results from this study are needed to support an Investigational New Drug (IND) application to advance this novel recombinant F protein particle based RSV (RSV-F) vaccine candidate into clinical development. This vaccine candidate is composed of recombinant 'F' or 'fusion' protein of RSV which is used by the virus to infect and fuse with cells in the respiratory tract and cause disease.
eCareSoft's eCS has received Complete Inpatient EHR Certification deeming the electronic health record (EHR) software capable of enabling hospitals and their affiliates to meet the Stage 1 meaningful use measures required to qualify for funding under the American Recovery and Reinvestment Act (ARRA).
CardioCell LLC announces two new clinical trials using its allogeneic stem-cell therapy to treat subjects with acute myocardial infarction (AMI), a problem facing more than 1.26 million Americans annually.
The Chemistry, Food & Drugs Division of the Trinidad & Tobago Ministry of Health approved the introduction of Telaprevir to the market, an innovative therapy that significantly increases the cure rate from Hepatitis C, and it is indicated for patients infected with the genotype 1 virus. Telaprevir is available in Trinidad under the trade brand INCIVO®.
› Verified 2 days ago
Matthew E Wolpoe, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 288 W Haley Springs Rd Ste 2a, Bozeman, MT 59718 Phone: 406-281-4392 | |
Dr. Hugh Elliott Hetherington, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 925 Highland Blvd Ste 1160, Bozeman, MT 59715 Phone: 406-414-3780 | |
Dr. Brennan Thomas Dodson, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1648 Ellis Street, Suite 301, Bozeman, MT 59715 Phone: 406-556-9798 Fax: 406-556-9795 |